Tatva Chintan Pharma Chem Stock

Tatva Chintan Pharma Chem P/E 2024

Tatva Chintan Pharma Chem P/E

77.11

Ticker

TATVA.NS

ISIN

INE0GK401011

As of Oct 2, 2024, Tatva Chintan Pharma Chem's P/E ratio was 77.11, a -4.39% change from the 80.65 P/E ratio recorded in the previous year.

The Tatva Chintan Pharma Chem P/E history

Tatva Chintan Pharma Chem Aktienanalyse

What does Tatva Chintan Pharma Chem do?

Tatva Chintan Pharma Chem ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Tatva Chintan Pharma Chem's P/E Ratio

The Price to Earnings (P/E) Ratio of Tatva Chintan Pharma Chem is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Tatva Chintan Pharma Chem's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Tatva Chintan Pharma Chem is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Tatva Chintan Pharma Chem’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Tatva Chintan Pharma Chem stock

What is the price-to-earnings ratio of Tatva Chintan Pharma Chem?

The price-earnings ratio of Tatva Chintan Pharma Chem is currently 77.11.

How has the price-earnings ratio of Tatva Chintan Pharma Chem changed compared to last year?

The price-to-earnings ratio of Tatva Chintan Pharma Chem has increased by -4.39% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Tatva Chintan Pharma Chem high compared to other companies?

Yes, the price-to-earnings ratio of Tatva Chintan Pharma Chem is high compared to other companies.

How does an increase in the price-earnings ratio of Tatva Chintan Pharma Chem affect the company?

An increase in the price-earnings ratio of Tatva Chintan Pharma Chem would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Tatva Chintan Pharma Chem affect the company?

A decrease in the price-earnings ratio of Tatva Chintan Pharma Chem would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Tatva Chintan Pharma Chem?

Some factors that influence the price-earnings ratio of Tatva Chintan Pharma Chem are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Tatva Chintan Pharma Chem pay?

Over the past 12 months, Tatva Chintan Pharma Chem paid a dividend of 2 INR . This corresponds to a dividend yield of about 0.19 %. For the coming 12 months, Tatva Chintan Pharma Chem is expected to pay a dividend of 2.39 INR.

What is the dividend yield of Tatva Chintan Pharma Chem?

The current dividend yield of Tatva Chintan Pharma Chem is 0.19 %.

When does Tatva Chintan Pharma Chem pay dividends?

Tatva Chintan Pharma Chem pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tatva Chintan Pharma Chem?

Tatva Chintan Pharma Chem paid dividends every year for the past 6 years.

What is the dividend of Tatva Chintan Pharma Chem?

For the upcoming 12 months, dividends amounting to 2.39 INR are expected. This corresponds to a dividend yield of 0.23 %.

In which sector is Tatva Chintan Pharma Chem located?

Tatva Chintan Pharma Chem is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Tatva Chintan Pharma Chem kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tatva Chintan Pharma Chem from 9/27/2024 amounting to 2 INR, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.

When did Tatva Chintan Pharma Chem pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Tatva Chintan Pharma Chem in the year 2023?

In the year 2023, Tatva Chintan Pharma Chem distributed 2 INR as dividends.

In which currency does Tatva Chintan Pharma Chem pay out the dividend?

The dividends of Tatva Chintan Pharma Chem are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tatva Chintan Pharma Chem

Our stock analysis for Tatva Chintan Pharma Chem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tatva Chintan Pharma Chem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.